Not disclosed
Filed Aug 6, 2026VivoSim Labs reported preliminary cash on hand of approximately $10.1 million as of August 3, 2026, confirmed compliance with Nasdaq Listing Rule 5550(b)(1), and anticipates 500%+ revenue growth in fiscal year 2027.
The filing provides a favorable fiscal year 2027 revenue-growth outlook and confirms Nasdaq minimum-stockholders'-equity compliance, but it does not disclose reported-period revenue, profitability, margins, cash flow, or operating metrics. The cash figure is preliminary and subject to financial closing procedures and final adjustments.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Preliminary cash on handother | approximately $10.1 million | – | – |
fiscal year 2027 outlook
- Revenue500%+ revenue growth
What drove it
- The Company anticipates 500%+ revenue growth in its fiscal year 2027.
- The Nasdaq Listing Qualifications Staff determined that the Company currently complies with Nasdaq Listing Rule 5550(b)(1), which requires registrants to maintain a minimum stockholders’ equity balance of $2.5 million.
Concerns
- The preliminary financial information reflects management’s current estimates and could be impacted by financial closing procedures, final adjustments, and other developments.
- The filing does not provide an actual revenue figure, profitability measures, margins, operating cash flow, free cash flow, or debt.
- The fiscal year 2027 revenue outlook is expressed only as 500%+ revenue growth, without a revenue base, revenue range, or other financial guidance.
What to watch
- Finalization of the preliminary cash-on-hand figure following financial closing procedures and final adjustments.
- Reported fiscal year 2027 revenue and the base against which the anticipated 500%+ revenue growth will be measured.
- Continued compliance with Nasdaq Listing Rule 5550(b)(1).
Balance sheet and cash flow
- Preliminary cash on hand as of August 3, 2026 was approximately $10.1 million.
Analysis
This Item 2.02 filing is a preliminary financial and corporate-status update rather than a complete earnings release. VivoSim Labs disclosed preliminary cash on hand of approximately $10.1 million as of August 3, 2026, but did not provide a fiscal reporting period, income statement, balance sheet, or cash flow statement.
The principal forward-looking disclosure is that the Company anticipates 500%+ revenue growth in its fiscal year 2027. The filing does not state the revenue amount from which this growth will be measured, nor does it provide revenue guidance in dollars, segment detail, gross-margin guidance, operating-expense guidance, tax-rate guidance, or profitability targets.
The company also disclosed that Nasdaq Listing Qualifications Staff determined that it currently complies with Nasdaq Listing Rule 5550(b)(1). The filing describes that rule as requiring registrants to maintain a minimum stockholders’ equity balance of $2.5 million. This is a listing-compliance determination, not a reported stockholders’ equity balance for VivoSim Labs.
The preliminary nature of the cash disclosure is important. Management stated that the information is based on currently available information and could be affected by financial closing procedures, final adjustments, and other developments. Investors will need the underlying periodic financial statements to assess revenue conversion, operating losses or income, cash burn, debt, and the durability of the fiscal year 2027 growth outlook.
No capital-return activity, debt balance, operating cash flow, free cash flow, segment performance, GAAP results, non-GAAP results, or executive commentary was included in the provided filing text. Accordingly, the disclosed outlook and preliminary liquidity figure are the only financial datapoints available for this read.
Not in the filing
stated, not guessed- Fiscal reporting period and period-end date.
- Actual total revenue and prior-year and prior-quarter revenue comparisons.
- Revenue growth for any reported period.
- Segment revenue, segment growth rates, and segment drivers.
- GAAP gross profit, gross margin, operating expenses, operating income or loss, net income or loss, and earnings per share.
- Non-GAAP gross margin, operating income or loss, net income or loss, and earnings per share.
- Operating cash flow and free cash flow.
- Cash-flow comparisons to prior periods.
- Debt, reported stockholders’ equity, and other balance-sheet balances.
- Share repurchases, dividends, and other capital-return activity.
- Fiscal year 2027 revenue amount or range, revenue comparison base, gross-margin guidance, operating-expense guidance, tax-rate guidance, and other financial guidance.
- Prior-period guidance for comparison.
- Named executive quotes or CFO commentary.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.